Stewart Fisher, Chief Scientific Officer at C4 Therapeutics, Inc. (CCCC), sold 68,315 shares at $45.00 ($3.1M) on 2021-07-29, disclosed to the SEC on 2021-08-02.
Open-market sale of $3.1M CCCC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 50,211 | $2.3M | 73.5% |
| 2 | $45.00 | 18,104 | $815K | 26.5% |
| Total | $45.00 avg | 68,315 | $3.1M | 100% |